Search research articles
Contact Us
Filters
Showing results (141-150 of 350) with videos related to
Page
of 35
Sort By:
Acta Gastro-Enterologica Belgica
|
March 9, 2007
Protein-losing enteropathy in Crohn's disease
Marc Ferrante, Freddy Penninckx, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis
|
March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study
Niels Vande Casteele, Filip Baert, Sumin Bian, et al.
Journal of Crohn'S & Colitis
|
November 1, 2015
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease
Severine Vermeire, Marie Joossens, Kristin Verbeke, et al.
Journal of Crohn'S & Colitis
|
May 1, 2015
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence
Marc Ferrante, Konstantinos Papamichael, Dana Duricova, et al.
Scandinavian Journal of Gastroenterology
|
June 17, 2017
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease
Thomas Billiet, Isabelle Cleynen, Vera Ballet, et al.
Inflammatory Bowel Diseases
|
August 28, 2015
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
Lize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Immunity, Inflammation and Disease
|
June 23, 2020
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells
Brecht Creyns, Jonathan Cremer, Gert De Hertogh, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases
Wannee Kantasiripitak, An Outtier, Sebastian G Wicha, et al.
Gut
|
April 12, 2015
Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
Filip Baert, Venkateswarlu Kondragunta, Steven Lockton, et al.
The American Journal of Gastroenterology
|
August 8, 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial
Neeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Page
of 35
Search research articles
Search
Showing results (141-150 of 350) with videos related to
Sort By:
Page
of 35
Acta Gastro-Enterologica Belgica
|
March 9, 2007
Protein-losing enteropathy in Crohn's disease
Marc Ferrante, Freddy Penninckx, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis
|
March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study
Niels Vande Casteele, Filip Baert, Sumin Bian, et al.
Journal of Crohn'S & Colitis
|
November 1, 2015
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease
Severine Vermeire, Marie Joossens, Kristin Verbeke, et al.
Journal of Crohn'S & Colitis
|
May 1, 2015
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence
Marc Ferrante, Konstantinos Papamichael, Dana Duricova, et al.
Scandinavian Journal of Gastroenterology
|
June 17, 2017
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease
Thomas Billiet, Isabelle Cleynen, Vera Ballet, et al.
Inflammatory Bowel Diseases
|
August 28, 2015
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
Lize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Immunity, Inflammation and Disease
|
June 23, 2020
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells
Brecht Creyns, Jonathan Cremer, Gert De Hertogh, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases
Wannee Kantasiripitak, An Outtier, Sebastian G Wicha, et al.
Gut
|
April 12, 2015
Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
Filip Baert, Venkateswarlu Kondragunta, Steven Lockton, et al.
The American Journal of Gastroenterology
|
August 8, 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial
Neeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Page
of 35